Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,446,831,079
-$675,531,209 QoQ
Shares Held
6,756,962
-23.9% QoQ
Ownership
1.25%
of shares outstanding
% of Portfolio
1.45%
of 13F equity value
Holder Rank
#11
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRIMECAP MANAGEMENT CO/CA/ holds $23,952,609,496 across 9 Drug Manufacturers - General names. AMGN ranks #4 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,172,904 | $11,002,257,162 | |
| 2 | AZN |
Astrazeneca PLC
|
18,095,178 | $3,431,207,652 | |
| 3 | BIIB |
Biogen Inc.
|
15,154,606 | $3,274,304,172 | |
| 4 | AMGN |
Amgen Inc
This page
|
6,756,962 | $2,446,831,079 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,923,900 | $1,436,115,118 | |
| 6 | GSK |
GSK plc
|
25,182,068 | $1,320,044,004 | |
| 7 | NVS |
Novartis AG
|
6,592,124 | $1,033,117,673 | |
| 8 | MRK |
Merck & Co., Inc.
|
35,700 | $4,587,450 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,446,831,079 | 6,756,962 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,122,362,288 | 8,874,129 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,914,688,676 | 8,904,979 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,739,487,259 | 9,707,609 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,968,479,469 | 10,631,709 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,859,573,307 | 12,388,295 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $3,388,873,860 | 13,002,125 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,593,406,749 | 14,255,941 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $4,514,004,831 | 14,447,127 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,151,628,698 | 14,601,958 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,202,634,613 | 14,591,468 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,959,495,412 | 14,732,458 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,271,783,298 | 14,736,435 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,653,495,950 | 15,112,703 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,016,346,822 | 15,292,213 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,508,321,698 | 15,564,870 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,804,876,246 | 15,638,620 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,802,874,620 | 15,726,055 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $3,549,161,590 | 15,776,155 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,419,983,390 | 16,082,687 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,960,711,300 | 16,249,072 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $4,148,800,259 | 16,674,572 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,903,771,903 | 16,978,827 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $4,424,183,961 | 17,407,082 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,236,736,669 | 17,962,930 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,746,468,645 | 18,480,090 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||